Vancouver, BC / ACCESSWIRE / December 22, 2014 / INVICTUS MD STRATEGIES CORP. (formerly BioAB Strategies Ltd.) ("Invictus MD" or the "Company") is pleased to announce that in furtherance to its press release dated December 19, 2014, Invictus MD's common shares will begin trading on the Canadian Securities Exchange under the trading symbol "IMH" as of market open tomorrow.
A message from Dan Kriznic, Invictus MD's Chief Executive Officer:
"A year ago Invictus MD was only a vision created by liked minded individuals in an industry that was controversial and evolving by the minute. Today the Company is focused on building a fully integrated medical cannabis organization. Invictus MD will begin trading on the Canadian Securities Exchange under the symbol IMH effective tomorrow, December 23, 2014.
We are currently applying to become a Licensed Producer under the Marihuana for Medical Purposes Regulations (Canada), seeking acquisition opportunities for on-line and on-the-ground Head Shops and developing a client management service line for existing Licensed Producers.
There are a number of initiatives that we have been working on in the medicinal cannabis space including three acquisition targets with combined revenues over the past 12 months of approximately $6.5 million. We will provide further updates in the coming weeks."
For further information, please contact:
Dan Kriznic, Chief Executive Officer & Director
Phone: 604-368-6437
Forward-Looking Statements
Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities laws. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements, including, among others, whether Invictus MD will ever become a Licensed Producer under the Marihuana for Medical Purposes Regulations (Canada), whether Invictus MD will continue to seek acquisition opportunities for on-line and on-the-ground Head Shops, whether Invictus MD will continue to develop a client management service line for existing Licensed Producers and whether Invictus MD will ever proceed with more definitive negotiations with the three acquisition targets referred to in this press release. Invictus MD undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. More detailed information about potential factors that could affect projected results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Invictus MD.
SOURCE: INVICTUS MD STRATEGIES CORP.